Modern clinical settings are rapidly adopting advanced diagnostic solutions within the Mycoplasma Pneumoniae Antibodies Market to improve patient outcomes. The move toward multiplex diagnostic platforms allows labs to test for multiple respiratory pathogens simultaneously, with Mycoplasma pneumoniae being a key target. This efficiency not only saves time but also significantly improves the...